TickerFacts.

AN2 Therapeutics, Inc. (ANTX): EPS (Basic)

Annual figures by period end, from SEC filings.

-$1.16
Year ended 2025-12-31
2021-12-31: -$10.642022-12-31: -$2.792023-12-31: -$2.742024-12-31: -$1.722025-12-31: -$1.16-$1.16
2021-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$1.16n/m2026-03-17, From 2025-01-01
2024-12-31-$1.72n/m2026-03-17, From 2024-01-01
2023-12-31-$2.74n/m2025-03-25, From 2023-01-01
2022-12-31-$2.79n/m2024-03-29, From 2022-01-01
2021-12-31-$10.64n/a2023-03-29, From 2021-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
AN2 Therapeutics, Inc. (ANTX)2025-12-31-$1.16n/m
Lifevantage Corp (LFVN)2026-06-30$0.40-50.0%
OnKure Therapeutics, Inc. (OKUR)2025-12-31-$4.40n/m
Q32 Bio Inc. (QTTB)2025-12-31$2.42n/m
Rallybio Corp (RLYB)2025-12-31-$1.59n/m
DiaMedica Therapeutics Inc. (DMAC)2025-12-31-$0.70n/m
Pasithea Therapeutics Corp. (KTTA)2025-12-31-$2.91n/m
ProPhase Labs, Inc. (PRPH)2025-12-31-$1.74n/m
Palvella Therapeutics, Inc. (PVLA)2025-12-31-$3.71n/m

Compare ANTX, LFVN, OKUR, QTTB side by side · Screen every company in Pharmaceutical Preparations ↗